Research

ADHD drugs 'do not stunt children's growth,' say AAP

ADHD drugs 'do not stunt children's growth,' say AAP (Medical News Today, September 1, 2014) "Attention Deficit Hyperactivity Disorder is one of the most common neurodevelopmental disorders of childhood, often lasting into adulthood. Though it is commonly treated with a "stimulant" medication, there have been concerns that such drugs could stunt a child's growth. Now, a new study suggests this type of medication does not affect children's final height in adulthood. The longitudinal study is published in the American Academy of Pediatrics' (AAP) journal Pediatrics..."

 

Potential New Treatment for AD/HD Predominantly Inattentive Presentation?

Potential New Treatment for AD/HD Predominantly Inattentive Presentation?

MDX: Promising Treatment for Inattentive ADHD?

A new medication has researchers paying close attention to its potential to improve focus and cognition in people with inattentive ADHD.

There may be hope on the horizon for those diagnosed with Predominantly Inattentive ADHD. A drug called Metadoxine Extended Release (MDX) — developed by Alcobra, a biopharmaceutical company focused on developing new medications to help patients...

Read More